Terms: = Liver cancer AND USP6, TRE2, 9098, ENSG00000129204, TRE17, Tre-2, HRP1 AND Treatment
4 results:
1. Weak linkage in hepatitis C PePHD: identification of mutation prone point that can lead to failure of antiviral therapy for prevention of hepatocellular carcinoma.
Wiwanitkit V
Asian Pac J Cancer Prev; 2007; 8(1):139-40. PubMed ID: 17477790
[TBL] [Abstract] [Full Text] [Related]
2. A very low toxic agent induces apoptosis and reduces growth of human hepatocellular carcinoma cells.
Schumacher G; Scheunert S; Rueggeberg A; Bachem MG; Nussler AK; Spinelli A; Mukhopadhyay T; Pratschke J; Neuhaus P
J Gastroenterol Hepatol; 2006 Jul; 21(7):1207-12. PubMed ID: 16824077
[TBL] [Abstract] [Full Text] [Related]
3. Percutaneous local ablation therapy in small hepatocellular carcinoma.
Lin SM; Lin DY
Chang Gung Med J; 2003 May; 26(5):308-14. PubMed ID: 12934846
[TBL] [Abstract] [Full Text] [Related]
4. Review article: percutaneous treatment of hepatocellular carcinoma.
Gaiani S; Celli N; Cecilioni L; Piscaglia F; Bolondi L
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():103-10. PubMed ID: 12786621
[TBL] [Abstract] [Full Text] [Related]
